Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 607851, 8 pages
http://dx.doi.org/10.1155/2012/607851
Clinical Study

Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma

Division of Gastroenterology and Hepatology, Toho University Medical Center, Omori Hospital, 6-11-1, Omorinishi, Ota-ku, Tokyo 143-8541, Japan

Received 26 December 2011; Revised 9 March 2012; Accepted 9 March 2012

Academic Editor: Julie R. Ostberg

Copyright © 2012 Hidenari Nagai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hidenari Nagai, Takanori Mukozu, Daigo Matsui, et al., “Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma,” Clinical and Developmental Immunology, vol. 2012, Article ID 607851, 8 pages, 2012. https://doi.org/10.1155/2012/607851.